Back to search
Non-valvular Atrial Fibrillation (NVAF)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Non-valvular Atrial Fibrillation (NVAF) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Non-valvular Atrial Fibrillation (NVAF) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Atrial fibrillation is the most common cardiac arrhythmia. In atrial fibrillation, there is a risk that clots can form in the heart, especially in the left atri…
To evaluate the preliminary safety and feasibility of the LAmbreTM II Left Atrial Appendage Occluder and the Occluder Delivery System in patients with non-valvu…
Background: Atrial fibrillation (AF) is the most common heart rhythm disorder worldwide. Globally, there are 37.5 million people with AF. AF increases the risk…
In the proposed event driven trial, LAA closure devices will be compared in a 1:1 randomization to best medical care in AF patients at high risk of stroke and b…
The purpose of this study is to prospectively evaluate the safety and effectiveness of the Amplatzer Amulet LAA occluder in a Chinese patient population indicat…
This study is a retrospective analysis of observational cohorts using data from prospectively collected administrative/claims data to investigate treatment patt…